During pre-patent infection, several consistent trends were observed in the sputum, including an increase in pro-inflammatory cytokines such as IL-1 and TNFα, warranting further studies of the respiratory response during pre-patent schistosomiasis, with an increased sample size. The gene discussed is IL1B; the disease is infection.